Search

everythinglearnresearchcommunity

for

Search:↓

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

A new method was developed to make finasteride for treating hair loss.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride may reduce depression and anxiety in female rats and improve brain connectivity.

Ruxolitinib can cause a delayed skin reaction on the nose.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Estrogen alone can lower testosterone in some transfeminine people.